Atlas Trials

A Study to Assess Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer Participants After Treatment Decentralization

Clinical trial NCT07527741 · RECRUITING

Trial details

NCT number
NCT07527741
Sponsor
Hoffmann-La Roche
Status
RECRUITING
Study type
OBSERVATIONAL
Early-stage HER2+ Breast Cancer
Start date
2026-02-23
Primary completion
2028-05-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.